Studying the effect of pulsed electromagnetic field on pain intensity and function in patients with myofascial pain of the upper and middle trapezius muscles

Investigating the effect of pulsed electromagnetic field on pain intensity and function in patients with myofascial pain of the upper and middle trapezius muscles referring to physical medicine clinics: A randomized controlled clinical trial study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180507039571N4

Enrollment

Registered

2025-02-07

Start date

2025-03-05

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome.

Interventions

Intervention 1: Intervention group: Pulse Electrical Magnetic Stimulation (Novinmed Company with a 70 cm diameter flavonoid cylindrical applicator) in the interfacial area of ??the trapezius muscle fo

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Diagnosis of myofascial pain syndrome is based on the presence of at least one tender point that is associated with spontaneous pain or with movement of the right or left upper trapezius muscle and produces similar pain or increases clinical symptoms with active pressure on the tender point with or without the presence of a taut band Normal neurological examination in the upper limb of the affected side Symptoms last at least one month Consent to participate in the study Age 18 to 80 years

Exclusion criteria

Exclusion criteria: Clinical symptoms of Fibromyalgia Mental retardation Upper limb nerve defects Advanced osteopathic/arthropathic disorders of the cervical spine or shoulder on the side being examined People with bleeding disorders Renal failure Severe liver disease Neoplasia Epilepsy Skin damage Patients with metal implants (clamps, heart valves, pacemakers) Pregnant women

Design outcomes

Primary

Measure	Time frame
Shoulder myofascial pain score on the Visual Analogue Scale questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and 14 days and 3 months after the end of treatment. Method of measurement: Using Visual Analogue Scale.;Shoulder pain and disability score based on the Shoulder Pain and Disability Index questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and 14 days and 3 months after the end of treatment. Method of measurement: Using the Shoulder Pain and Disability Index questionnaire.	—

Measure

Time frame

Shoulder myofascial pain score on the Visual Analogue Scale questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and 14 days and 3 months after the end of treatment. Method of measurement: Using Visual Analogue Scale.;Shoulder pain and disability score based on the Shoulder Pain and Disability Index questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and 14 days and 3 months after the end of treatment. Method of measurement: Using the Shoulder Pain and Disability Index questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShervin Ghaffari Hoseini

Esfahan University of Medical Sciences

shghaffari@yahoo.com+98 31 3611 5208

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026